Hematologist
CION Cancer Clinics
When AML needs a transplant | CION Cancer Clinics
Not every person with AML needs a bone marrow transplant. It is usually advised in first remission for intermediate or adverse-risk AML, for leukaemia still found on sensitive tests, and for AML that returns. Favourable-risk AML is often treated with chemotherapy alone. This page explains how the decision is made, the steps to finding a donor, and who a transplant does not suit. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Does every person with AML need a bone marrow transplant?
- When is a transplant usually recommended?
- What are the steps towards a transplant?
- How does a transplant compare with chemotherapy alone?
- What do the transplant words mean?
- What do families often believe about transplant in AML?
- Who is a transplant not right for?
- Common questions about transplant in AML
The short answer
Does every person with AML need a bone marrow transplant?
No. A transplant is usually advised in first remission for AML with intermediate or adverse genetic risk, for leukaemia still found on sensitive tests, and for AML that has come back. Favourable-risk AML is often treated with chemotherapy alone, keeping transplant in reserve.
Why a transplant is used in AML
In AML, the transplant used is almost always allogeneic, meaning the stem cells come from a donor. Strong treatment first clears the marrow. The donor's cells then rebuild it, and the donor's immune cells attack leukaemia cells left behind. That immune effect is the main reason a transplant lowers the chance of relapse.
Why it is not offered to everyone
A transplant carries serious risks of its own: infections, organ damage and graft-versus-host disease, where the donor's immune cells attack the patient's body. If the leukaemia is unlikely to come back after chemotherapy, those risks may outweigh the benefit. The decision always weighs the risk from the leukaemia against the risk from the transplant.
The timing question
Transplant works most effectively when AML is in remission. That is why many teams start looking for a donor early, often during induction, even before the final decision is made. Waiting until relapse can mean a harder transplant, or none at all.
CION does not perform transplants. CION's haematology team reviews the case, takes it to a tumour board and coordinates referral to qualified transplant centres.By situation
When is a transplant usually recommended?
These are general patterns. Your haematologist may advise differently for good reasons.
Favourable risk
For example NPM1 without other adverse changes, or core-binding factor AML. Chemotherapy consolidation is usually preferred.
Transplant may come up if
- Residual disease tests stay positive
- The leukaemia comes back
Intermediate risk
Transplant in first remission is often considered for fit people with a suitable donor. The decision leans on residual disease results and general health.
This is the group where opinions differ most.Adverse risk
For example complex chromosome changes or certain high-risk mutations. Transplant in first remission is generally advised for people fit enough.
Relapsed or hard-to-treat AML
A transplant is often the main option for lasting control, if a second remission can be reached and the person is fit enough.
Not sure whether this applies to you?
Ask an oncologistThe pathway
What are the steps towards a transplant?
-
Genetic and risk results
Marrow tests at diagnosis place the AML in a risk group. This is when the question of transplant is first raised.
-
Tissue typing of the patient and siblings
HLA typing is a blood test that checks how closely a possible donor matches. Brothers and sisters are usually tested first. Ask the team which laboratory will do it and how to send samples from family members who live elsewhere.
-
Donor search
If no sibling matches, the transplant centre may search donor registries or consider a half-matched family donor, such as a parent or child.
-
Reaching remission
Induction and consolidation continue while the donor is found.
-
Assessment at the transplant centre
Heart, lung, kidney and infection tests, and a detailed talk about risks, costs and the length of stay.
-
Transplant and recovery
Conditioning treatment, the stem cell infusion, weeks in hospital and months of close follow-up near the centre.
Side by side
How does a transplant compare with chemotherapy alone?
Chemotherapy consolidation
Donor stem cell transplant
Higher chance of relapse in higher-risk AML
Lower chance of relapse for many higher-risk types
Fewer serious treatment risks
Serious risks, including graft-versus-host disease
Given at many haematology centres
Needs a qualified transplant centre
No donor needed
Needs a matched or half-matched donor
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
In the transplant discussion
What do the transplant words mean?
- Allogeneic transplant
- Stem cells from a donor. This is the type used for AML.
- HLA match
- How closely the donor's tissue type matches the patient's.
- Haploidentical
- A half-matched family donor, such as a parent, child or sibling.
- Conditioning
- Chemotherapy, sometimes with radiation, given just before the transplant to clear the marrow.
- Graft-versus-host disease
- The donor's immune cells attacking the patient's skin, gut or liver.
Commonly believed
What do families often believe about transplant in AML?
"A transplant means the leukaemia will never return."
A transplant lowers the chance of relapse for many people, but it can still come back. Follow-up continues for years, and the team watches for late effects on the heart, hormones, eyes and bones as well as for relapse.
"Without a perfectly matched sibling, there is no transplant."
Registry donors and half-matched family donors are now widely used. Not having a matched sibling does not rule out a transplant.
"We should wait and see if chemotherapy is enough."
For higher-risk AML, transplant usually works better in first remission. Start the donor search early, even if the final decision comes later.
"Giving stem cells is dangerous for the donor."
For most healthy donors, stem cells are collected from the blood over a day or two, and serious problems are uncommon. The donor is checked carefully before agreeing.
Being straight with you
Who is a transplant not right for?
A transplant is not suitable for many older adults, people with serious heart, lung, kidney or liver problems, and people whose AML cannot be brought into remission. For them, the risks of the transplant are too likely to outweigh the gain. Lower-intensity treatment or supportive care may be a better fit. A transplant also needs a full-time carer for months and a stay near the centre. If that cannot be arranged, say so early, because it changes the plan and there may be ways to help.
What this page cannot tell you
It cannot tell you whether your family member needs a transplant, or what the chances of success would be. That depends on the genetic results, residual disease tests, fitness and donor options. The transplant centre gives its own assessment, including the risks for this person. For the wider picture of what a transplant involves, see the main bone marrow transplant guide.
Questions worth asking the team
Is a transplant recommended, and why? Should siblings be tested now? Which transplant centres will you refer us to? What will it cost, and what do our scheme or insurance cover? How long will we need to stay near the centre? Families from Telangana and Andhra Pradesh districts should plan for time away from home.
Questions we are asked
Common questions about transplant in AML
Can an autologous transplant using the patient's own cells be used for AML?
Rarely. A transplant using your own cells does not bring the donor immune effect that helps control AML, and the collected cells could contain leukaemia. Donor transplants are the standard in AML. A few centres use own-cell transplants in selected situations, and your haematologist can explain if it applies.
Which family members should be tested as donors?
Full brothers and sisters are usually tested first, because they have the highest chance of a full match. Parents, children and siblings may be considered as half-matched donors. The transplant team decides who to test. Ask early, because family members may live in other cities.
Does CION do the transplant?
No. CION's haematology team evaluates the case, presents it to a tumour board and coordinates referral to qualified transplant centres. The team can help you understand the reports and prepare questions before you meet the transplant centre.
Is there an age limit for transplant in AML?
There is no single cut-off. Fitness, other illnesses and the leukaemia type matter more than age. Gentler conditioning, called reduced-intensity, has made transplant possible for some older adults. Many people in their seventies are still not suitable. The transplant centre decides after a full assessment.
How long will we need to stay near the transplant centre?
Usually several months, including the hospital stay and close follow-up afterwards. Frequent visits are needed in the early period to watch for infections and graft-versus-host disease. Ask the centre for its own plan, and arrange accommodation and a full-time carer before admission.
Is a transplant covered by Aarogyasri or insurance?
Some transplants are covered in part under Aarogyasri, PM-JAY, CGHS, ECHS, EHS or cashless insurance, depending on the scheme, the centre and the type of transplant. Rules change, so check the current entitlement with the transplant centre and your scheme before admission.
What if no donor can be found?
Half-matched family donors and cord blood are options at some centres, so this is less common than it once was. If a transplant is still not possible, further chemotherapy or other treatments can be used. Your haematologist will explain the choices.
Can a transplant be done if AML comes back afterwards?
Sometimes, but options are more limited. The team may use further treatment, donor immune cell infusions, or rarely a second transplant. It depends on how long remission lasted and the person's health. The transplant centre will discuss what is realistic.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Stem Cell Transplants in Cancer Treatment
- Cancer Research UK — Treatment for acute myeloid leukaemia (AML)
- American Cancer Society — Treating Acute Myeloid Leukemia (AML)
- Leukemia & Lymphoma Society — Acute Myeloid Leukemia
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Told a transplant might be needed?
Tell us what has been found so far. CION's haematology team will review the reports and help coordinate with qualified transplant centres. One helpline serves every CION centre.